JYNT - NASDAQ
The Joint Corp.
$8.27
-0.54%The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
At a Glance
Live SnapshotThe Joint Corp. Management Team
Mr. Sanjiv Razdan
Chief Executive Officer, President & Director
Compensation
$693,819
Mr. Jake Singleton CPA
Chief Financial Officer
Compensation
$426,952
Ms. Lori I. Abou Habib
Chief Marketing Officer
Mr. Charles Nelles
Chief Technology Officer
Mr. Craig P. Colmar J.D.
Secretary
Compensation
$37,000
Mr. Craig M. Sherwood
Senior Vice President of Development
Ms. Beth Gross
Senior Vice President of Human Resources
Ms. Andra J. Terrell
Senior Vice President of Legal
Mr. Eric Wyatt
Senior Vice President of Operations & Patient Experience
Dr. Steven Knauf
Vice President of Chiropractic & Compliance
The Joint Corp. Insider Positioning
During the last 12 months, insiders have purchased $2.34M worth of JYNT shares, with no selling activity reported.
3 Months
148.6K
1.27M
0
0.00
+1.3M
+$1.27M
3-6 Months
40.0K
368.35K
0
0.00
+368K
+$368K
6-9 Months
39.8K
335.10K
0
0.00
+335K
+$335K
9-12 Months
34.4K
367.59K
0
0.00
+368K
+$368K
Top Buyers
Jobson Charles E
10 Percent Owner
$1.98M
Grandpre Christopher M
Director
$368K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $2.34M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
2 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
JYNT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | April 07, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 08, 2025 | April 08, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 19, 2024 | April 19, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 21, 2023 | May 25, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 22, 2022 | May 26, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 23, 2021 | May 28, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 24, 2020 | May 29, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 26, 2019 | May 31, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 27, 2018 | June 01, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 28, 2017 | June 02, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.